Harry Spoelstra: Omicron COVID-19 and Coronary Thrombosis Without Atherosclerosis
Harry Spoelstra, CardioVascular Surgeon, shared a post on X about a recent article by Ming-Lian Gonget al, published in Journal of Medical Case Reports, adding:
”Coronary thrombosis without underlying atherosclerotic plaque in patients with Omicron variant of coronavirus disease 2019: a case series
As I’ve warned you, Omicron COVID-19 can trigger massive heart attacks in patients with perfectly clean arteries. More evidence below.
This small case series preprint describes three Chinese patients with Omicron-variant COVID-19 who developed acute myocardial infarction (AMI) caused by coronary thrombosis without underlying atherosclerotic plaque on coronary angiography (CAG).
Case Details:
- 33-year-old man: mild chest pain with a massive thrombus in the left anterior descending (LAD) artery (TIMI 2 flow), which resolved spontaneously with antithrombotic therapy.
- 76-year-old man: severe COVID-19 pneumonia and AMI complicated by ventricular septal defect and cardiogenic shock, with no plaque in any vessel.
- 76-year-old woman (history of atrial fibrillation): AMI from right coronary artery thrombus plus venous thromboembolism, and repeat CAG confirmed thrombus resolution without plaque.
Key Findings:
- All patients showed ST-elevation or equivalent AMI on ECG.
- Echocardiography revealed regional wall-motion abnormalities (plus VSD in one case).
- Thrombosis resolved with anticoagulation (heparin/rivaroxaban) plus dual antiplatelet therapy.
- No stenting or thrombectomy was needed in most cases.
Mechanisms and Management:
- Omicron-driven cytokine storm induces endothelial damage and hypercoagulability, enabling de novo thrombosis.
- Prompt CAG, primary PCI when feasible, intensive antithrombotic therapy, and a multidisciplinary Heart Team approach were critical.
Conclusion:
- Omicron-variant COVID-19 markedly increases thrombogenicity, causing coronary thrombosis and AMI even in the absence of atherosclerotic plaque.
- Early recognition, aggressive anticoagulation/antiplatelet therapy, and coordinated Heart Team care enable favorable outcomes despite high-risk presentations.
- The report underscores the need for heightened vigilance for thrombotic complications in COVID-19.
Title: Coronary thrombosis without underlying atherosclerotic plaque in patients with Omicron variant of coronavirus disease 2019: a case series
Authors: Ming-Lian Gong, Yi Mao
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 7, 2026, 06:19Simone Schoenwaelder: Women Are 25% More Likely to Have Their Stroke Misdiagnosed and Here’s Why
-
Jul 7, 2026, 06:12Dhiraj Bhatia: Extremely Happy to Share Our Review on DNA Nanotechnology in Stroke Repair
-
Jul 7, 2026, 06:04Brian A Beh: An Open Letter to Lisa Murphy Honouring the 30 Years of the Stroke Foundation’s Dedication
-
Jul 7, 2026, 05:55Alan Nurden: A Landmark Review Comparing Hemophilia and Hereditary Angioedema
-
Jul 7, 2026, 05:40Andrew Agwunobi: UConn Health is Proud to Advance Stroke Rehabilitation for Veterans
-
Jul 6, 2026, 22:54Louise St. Germain Bannon: I Wanted to Recognize the Incredible Staff Behind ISTH 2026
-
Jul 6, 2026, 21:46Armghan Ans: UPMC Washington Stroke Program Earns AHA Gold Plus Award for 16th Consecutive Year
-
Jul 6, 2026, 20:31Manik Madaan: Master Transfusion Reactions for USMLE In Less Than 60 Seconds
-
Jul 6, 2026, 19:25Ambreen Kashif: Highlighting the Impact of Temporary Donor Deferrals on Donor Retention